Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 1, p. s8, 2021. DOI: 10.25251/skin.5.supp.8. Disponível em: https://skin.dermsquared.com/skin/article/view/1161. Acesso em: 19 apr. 2025.